Harrow Health(IMMY)

Imprimis Pharmaceuticals和 Compounding Pharmacy

淘沙见金2017-10-30 11:45

这个制药公司Imprimis Pharmaceuticals $Imprimis Pharmaceuticals, Inc.(IMMY)$ 大涨，原因是因为公司称将会提供比AGN的干眼症治疗药物Restasis更为便宜的替代选择。这个药物第一个月只需要不到1美元，以后每个月花费79美元。对比Restasis每年的花费高达5000美元一年确实便宜不少。听起来很美好...查看全文

Vodka配鱼油救命药2017-10-20 09:45

$Imprimis Pharmaceuticals, Inc.(IMMY)$
IMMY买入原因：今天IMMY发的干眼症药物为Restasis的仿制药，RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%，现有竞争对手仅有Shire’s idra，占20%的市场。IMMY的仿制药由于是走低价路线，有可...查看全文

TLS美股研究2017-04-09 21:31

回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88，也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注，眼科市场天花板逐渐打开，公司高管参与增发，市值迷你，会是小黑马吗 查看全文

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-07-02 AccNo: 0001493152-18-009586 Size: 61 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07: Submission of Matters to a Vote of Security HoldersItem 9.01: Fin...

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-06-01 AccNo: 0001493152-18-008102 Size: 13 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-05-15 AccNo: 0001493152-18-007074 Size: 116 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-15 AccNo: 0001493152-18-007073 Size: 4 MB 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-05-15 AccNo: 0001493152-18-006896 Size: 358 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-30 AccNo: 0001493152-18-006011 Size: 1 MB 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-04-13 AccNo: 0001493152-18-005111 Size: 26 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ PRE 14A - Other preliminary proxy statements Filed: 2018-04-12 AccNo: 0001493152-18-005089 Size: 502 KB 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-03-12 AccNo: 0001493152-18-003202 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$Imprimis Pharmaceuticals, Inc.(IMMY)$ 8-K - Current report Filed: 2018-03-08 AccNo: 0001493152-18-003097 Size: 105 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接